Position in AMPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,234,399
-$7,609,475 QoQ
Shares Held
420,337
-29.0% QoQ
Ownership
0.953%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.01661761872022.ToString("F0")%
Shared 0.ToString("F0")%
None 4.983382381279783.ToString("F0")%
Common Shares in AMPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $4,148,184,090 across 73 Drug Manufacturers - Specialty & Generic names. AMPH ranks #31 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,145,735 | $1,672,167,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
409,288 | $242,699,592 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,426,253 | $223,678,734 | |
| 4 | VTRS |
Viatris Inc
|
16,089,939 | $217,375,067 | |
| 5 | HLN |
Haleon plc
|
19,166,253 | $191,854,187 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
8,889,088 | $184,537,462 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
1,219,196 | $160,616,870 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
6,417,527 | $153,571,413 |
All Filings in AMPH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,234,399 | 420,337 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,843,874 | 591,631 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $15,315,193 | 574,679 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $15,640,855 | 681,222 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $15,136,022 | 522,112 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $23,468,904 | 632,074 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $32,885,187 | 677,626 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $24,405,480 | 610,137 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $24,547,397 | 559,039 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $35,323,335 | 571,113 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $25,672,027 | 558,209 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $32,574,855 | 566,815 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,501,610 | 520,043 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,897,401 | 603,048 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,961,786 | 710,384 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,764,055 | 826,791 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $20,189,976 | 562,395 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $14,410,497 | 618,742 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,836,435 | 517,435 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,350,772 | 414,225 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $6,258,110 | 341,600 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,674,668 | 331,908 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,815,711 | 96,838 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,746,430 | 122,281 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,481,744 | 234,619 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||